Vaccination strategies in tauopathies and synucleinopathies-Reference-Cited by-同舟云学术

Vaccination strategies in tauopathies and synucleinopathies

Published:2017-10-16 Issue:5 Volume:143 Page:467-488
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Braczynski Anne K.¹^ORCID,Schulz Jörg B.¹²^ORCID,Bach Jan-Philipp¹

Affiliation:

1. Department of Neurology; RWTH Aachen University Hospital; Aachen Germany

2. Jülich Aachen Research Alliance (JARA) - JARA-Institute Molecular Neuroscience and Neuroimaging; FZ Jülich and RWTH University; Aachen Germany

Funder

RWTH Aachen University

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.14207/fullpdf

Reference142 articles.

1. Defects in trafficking bridge Parkinson's disease pathology and genetics;Abeliovich;Nature,2016

2. Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity;d'Abramo;PLoS ONE,2013

3. Characterization of the epitope specificity of naturally occurring autoantibodies against α-synuclein, β-amyloid and prion protein [abstract];Albus;Mov. Disord.,2014

4. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein;Allen;J. Neurosci.,2002

5. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules;Alonso;Nat. Med.,1996

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review and recent advancement in the application of tannins for treating Parkinson disease;Pharmacological Research - Modern Chinese Medicine;2024-09

2. Neurodegeneration and inflammation crosstalk: Therapeutic targets and perspectives;IBRO Neuroscience Reports;2023-06

3. Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease;Stem Cell Research & Therapy;2023-04-12

4. Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates;npj Vaccines;2022-10-12

5. Traumatic Brain Injury and Secondary Neurodegenerative Disease;Trauma Care;2022-09-26